Audit 321465

FY End
2023-12-31
Total Expended
$17.44M
Findings
0
Programs
16
Organization: Vitalant (AZ)
Year: 2023 Accepted: 2024-09-26

Organization Exclusion Status:

Checking exclusion status...

Findings

No findings recorded

Programs

ALN Program Spent Major Findings
93.RD Covid-19 - National Sars-Cov-2 Seroincidence Studies in Blood Donors $6.47M Yes 0
93.RD Recipient Epidemiology and Donor Evaluation Study IV - Pediatric (reds-IV-P) - Center for Transfusion Laboratory Studies (ctls) $2.59M Yes 0
93.RD Transfusion-Transmissible Infections Monitoring System (ttims) Laboratory and Risk Factor Coordinating Center (lrcc) $1.97M Yes 0
93.RD Recipient Epidemiology and Donor Evaluation Study IV - Pediatric (reds-IV-P) Brazil Transfusion Safety Research Program $1.34M Yes 0
93.RD Recipient Epidemiology and Donor Evaluation Study IV - Pediatric (reds-IV-P) - Domestic Hub $618,628 Yes 0
93.RD Niaid Virology Quality Assurance (vqa) $339,172 Yes 0
93.RD Niaid External Quality Assurance Program Oversight Laboratory (eqapol) $249,203 Yes 0
93.RD External Quality Assurance Program Oversight Laboratory (eqapol) $234,120 Yes 0
93.067 Global Aids $168,517 - 0
93.RD Transfusion-Transmissible Infections Monitoring System (ttims) - Donation Database Coordinating Center (ddcc) $146,921 Yes 0
93.866 Aging Research $92,424 Yes 0
93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders $80,258 Yes 0
93.839 Blood Diseases and Resources Research $60,273 Yes 0
93.855 Allergy and Infectious Diseases Research $52,645 Yes 0
93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research $24,951 Yes 0
93.RD Development, Validation & Use of Biotinylation to Measure Post-Transfusion Red Blood Cell Kinetrics in the Context of Regulatory Studies for the Approval of Novel Or Modified Blood Products in the USA $719 Yes 0

Contacts

Name Title Type
GKT4L2JZJ622 Steven Sweet Auditee
4157496613 Scott Enos Auditor
No contacts on file

Notes to SEFA

Title: 1. Summary of Significant Accounting Policies Accounting Policies: The accompanying Schedule of Expenditures of Federal Awards (SEFA) includes the federal grant activity of Vitalant and Affiliates and is presented on the accrual basis of accounting. The information in the SEFA is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). The SEFA does not include payments received under the traditional Medicare and Medicaid reimbursement programs, as these programs are outside the scope of the Uniform Guidance. There were no donated goods and personal protective equipment received from federal sources that required recognition or disclosure in the notes to the SEFA. De Minimis Rate Used: N Rate Explanation: Vitalant and Affiliates utilizes the Department of Health and Human Services negotiated indirect cost rate. Basis of Accounting: The accompanying Schedule of Expenditures of Federal Awards (SEFA) includes the federal grant activity of Vitalant and Affiliates and is presented on the accrual basis of accounting. The information in the SEFA is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). The SEFA does not include payments received under the traditional Medicare and Medicaid reimbursement programs, as these programs are outside the scope of the Uniform Guidance. There were no donated goods and personal protective equipment received from federal sources that required recognition or disclosure in the notes to the SEFA.
Title: 2. Indirect Costs Accounting Policies: The accompanying Schedule of Expenditures of Federal Awards (SEFA) includes the federal grant activity of Vitalant and Affiliates and is presented on the accrual basis of accounting. The information in the SEFA is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). The SEFA does not include payments received under the traditional Medicare and Medicaid reimbursement programs, as these programs are outside the scope of the Uniform Guidance. There were no donated goods and personal protective equipment received from federal sources that required recognition or disclosure in the notes to the SEFA. De Minimis Rate Used: N Rate Explanation: Vitalant and Affiliates utilizes the Department of Health and Human Services negotiated indirect cost rate. Vitalant and Affiliates does not use the 10 percent de minimis indirect cost rate provided for in the Uniform Guidance.
Title: 3. Assistance Listing Numbers Accounting Policies: The accompanying Schedule of Expenditures of Federal Awards (SEFA) includes the federal grant activity of Vitalant and Affiliates and is presented on the accrual basis of accounting. The information in the SEFA is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). The SEFA does not include payments received under the traditional Medicare and Medicaid reimbursement programs, as these programs are outside the scope of the Uniform Guidance. There were no donated goods and personal protective equipment received from federal sources that required recognition or disclosure in the notes to the SEFA. De Minimis Rate Used: N Rate Explanation: Vitalant and Affiliates utilizes the Department of Health and Human Services negotiated indirect cost rate. The program titles and assistance listing numbers were obtained from the respective grant agreements. Per the Federal Audit Clearinghouse instructions, Vitalant and Affiliates should report the awarding federal agency’s two-digit prefix, followed by the three-digit assistance listing extension number. If the three-digit assistance listing extension number is unknown, then the awarding federal agency’s two-digit prefix is followed by “RD” (Research and Development), as well as including the federal contract number as an additional identifier.